<![CDATA[Biotek-snakken — April 2026]]>OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1427678/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked

]]>https://dev.proinvestor.com/forum/topic/401466/biotek-snakken-april-2026RSS for NodeSat, 06 Jun 2026 04:09:39 GMTWed, 01 Apr 2026 06:02:25 GMT60<![CDATA[Reply to Biotek-snakken — April 2026 on Thu, 30 Apr 2026 02:54:26 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068757https://dev.proinvestor.com/forum/post/8068757Thu, 30 Apr 2026 02:54:26 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Wed, 29 Apr 2026 07:05:20 GMT]]>Initiator Pharma A/S: Enrolment on track - fair value range 6,8–9,3 SEK (DNB Carnegie)
Recruitment in the important vulvodynia study appears to be on track, with half of the planned patients already dosed. We find the positive development encouraging. We believe a positive outcome could represent a key value inflection point, and estimate peak sales of approximately USD1.6bn, risk-adjusted at a 15% LOA. https://access.dnbcarnegie.com/publication/e46d158f-68fe-43f0-58cb-08dea508df61

]]>https://dev.proinvestor.com/forum/post/8068756https://dev.proinvestor.com/forum/post/8068756Wed, 29 Apr 2026 07:05:20 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Wed, 29 Apr 2026 02:53:06 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068760https://dev.proinvestor.com/forum/post/8068760Wed, 29 Apr 2026 02:53:06 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Tue, 28 Apr 2026 19:40:21 GMT]]>
Link Preview Image
Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration

Opt-out election makes Protagonist eligible for $200 million upon exercise and an additional $200 million upon FDA approval of rusfertide for polycythemia vera Approval would also trigger a $75 million milestone payment, bringing total potential cash ...

favicon

Yahoo Finance (finance.yahoo.com)

]]>https://dev.proinvestor.com/forum/post/8068754https://dev.proinvestor.com/forum/post/8068754Tue, 28 Apr 2026 19:40:21 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Tue, 28 Apr 2026 19:40:17 GMT]]>Flot opt-out aftale til Protagonist

]]>https://dev.proinvestor.com/forum/post/8068755https://dev.proinvestor.com/forum/post/8068755Tue, 28 Apr 2026 19:40:17 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Tue, 28 Apr 2026 17:10:12 GMT]]>Initiator Pharma A/S rapporterer fremskridt i patientrekrutteringen til fase 2a-studie i vulvodyni https://www.nordnet.dk/markedet/nyheder/4a963de2-45da-4f01-9de5-b12683953745

]]>https://dev.proinvestor.com/forum/post/8068752https://dev.proinvestor.com/forum/post/8068752Tue, 28 Apr 2026 17:10:12 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Tue, 28 Apr 2026 02:56:24 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068759https://dev.proinvestor.com/forum/post/8068759Tue, 28 Apr 2026 02:56:24 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Mon, 27 Apr 2026 02:48:48 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068758https://dev.proinvestor.com/forum/post/8068758Mon, 27 Apr 2026 02:48:48 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Fri, 24 Apr 2026 04:15:04 GMT]]>God morgen. 🙂

]]>https://dev.proinvestor.com/forum/post/8068748https://dev.proinvestor.com/forum/post/8068748Fri, 24 Apr 2026 04:15:04 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Fri, 24 Apr 2026 02:56:47 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068749https://dev.proinvestor.com/forum/post/8068749Fri, 24 Apr 2026 02:56:47 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Thu, 23 Apr 2026 02:57:44 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068751https://dev.proinvestor.com/forum/post/8068751Thu, 23 Apr 2026 02:57:44 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Wed, 22 Apr 2026 03:00:34 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068747https://dev.proinvestor.com/forum/post/8068747Wed, 22 Apr 2026 03:00:34 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Tue, 21 Apr 2026 03:06:18 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068746https://dev.proinvestor.com/forum/post/8068746Tue, 21 Apr 2026 03:06:18 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Mon, 20 Apr 2026 03:03:17 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8068750https://dev.proinvestor.com/forum/post/8068750Mon, 20 Apr 2026 03:03:17 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Fri, 17 Apr 2026 10:08:02 GMT]]>Novo og Lilly kan se opkomling blive børsnoteret https://proinvestor.com/investornyt/1433039/novo-og-lilly-kan-se-opkomling-blive-borsnoteret

]]>https://dev.proinvestor.com/forum/post/8068743https://dev.proinvestor.com/forum/post/8068743Fri, 17 Apr 2026 10:08:02 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Fri, 17 Apr 2026 02:42:58 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8068744https://dev.proinvestor.com/forum/post/8068744Fri, 17 Apr 2026 02:42:58 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Thu, 16 Apr 2026 15:04:11 GMT]]>Er der nogen der ved hvad den store stigning i Ascelia kommer af. Kan ikke finde noget på deres hjemmeside.

]]>https://dev.proinvestor.com/forum/post/8068753https://dev.proinvestor.com/forum/post/8068753Thu, 16 Apr 2026 15:04:11 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Tue, 14 Apr 2026 10:15:39 GMT]]>PHOTOCURE: ABG oppgraderer aksjen fra hold til kjøp og øker kursmålet til NOK 80 (72).

]]>https://dev.proinvestor.com/forum/post/8068741https://dev.proinvestor.com/forum/post/8068741Tue, 14 Apr 2026 10:15:39 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Mon, 13 Apr 2026 17:52:49 GMT]]>Jo det er jo netop Ecor1 der har styret hele strategiskiftet, bl.a ved nye folk i BD og de nye royalty pharma aftaler. EcoR1 er ved at forvandle Zymeworks fra et rodet biotekselskab til et rent, cashflow-genererende aktiv — præcis den type virksomhed, Big Pharma køber. Samme metode blev brugt på Horizon pharma. Mindre risikofyldt R&D, mere stabil cashflow
.vil med tiden efter en phase 1 eller 2 deal på zw191 ligne et et finansielt aktiv, ikke et usikkert biotech-bet.

]]>https://dev.proinvestor.com/forum/post/8068737https://dev.proinvestor.com/forum/post/8068737Mon, 13 Apr 2026 17:52:49 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Sat, 11 Apr 2026 07:36:56 GMT]]>De kommende år vil vise om Genmab valgte rigtigt med at gå den vej - personligt har de skuffet lidt med udvikling af egne kandidater, men hvis potosemtamab og RinaS går hele vejen, så skal det nok blive godt.

]]>https://dev.proinvestor.com/forum/post/8068742https://dev.proinvestor.com/forum/post/8068742Sat, 11 Apr 2026 07:36:56 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Sat, 11 Apr 2026 07:34:49 GMT]]>Synes stadig det er en lidt underlig strategi, for den kan vel både bevidne og stor svaghed eller styrke i deres interne forskning. Har det meget fint med, at de ikke selv vil til at sælge lægemidler og vælger denne del fra. Det samme gør eks Protagonist Therapeutics. Det er et stort spring og kræver massive investeringer, så nogengange bedre at fortsætte med det man er god til.

]]>https://dev.proinvestor.com/forum/post/8068739https://dev.proinvestor.com/forum/post/8068739Sat, 11 Apr 2026 07:34:49 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Sat, 11 Apr 2026 07:30:58 GMT]]>Lahn1 spørgsmålet er jo hvad Ecor1 vil med Zymeworks - er du sikker på at det ikke netop er dem, som har sat denne royalty strategi i søen. Nu har de fået to personer ind på vigtige positioner, så det er vel snarere at de former Zymeworks, som de selv gerne ville have gjort - om formålet så er et salg på den lidt længere bane er vel muligt.

]]>https://dev.proinvestor.com/forum/post/8068745https://dev.proinvestor.com/forum/post/8068745Sat, 11 Apr 2026 07:30:58 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Sat, 11 Apr 2026 02:48:31 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8068738https://dev.proinvestor.com/forum/post/8068738Sat, 11 Apr 2026 02:48:31 GMT<![CDATA[Reply to Biotek-snakken — April 2026 on Sat, 11 Apr 2026 00:49:22 GMT]]>Det er den mest stigende biotek aktie i Norge i år. Der er også en dansk FB gruppe. En meget spændende aktie. https://www.facebook.com/groups/772926445645299

]]>https://dev.proinvestor.com/forum/post/8068734https://dev.proinvestor.com/forum/post/8068734Sat, 11 Apr 2026 00:49:22 GMT